Page 216 - Genentech News Today

Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency - read this article along with other careers information, tips and advice on BioSpace

Multi-year collaboration focuses on three strategic pillars: cancer immunotherapies, infectious disease vaccines, and expansion of BioNTech's footprint in the UKBioNTech aims to design and roll out randomized

Investegate announcements from F. Hoffmann-La Roche Ltd, FDA grants priority review to Roche’s bispecific antibody glofitamab for people with relapsed or refractory large B-cell lymphoma

Investegate announcements from BioNTech SE, BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as...

06.01.2023 - BRISBANE, Calif., Jan. 06, 2023 (GLOBE NEWSWIRE) - Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, ...

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European stocks were narrowly mixed on Friday, as investors awaited Eurozone inflation data and the all-important U.S. jobs data later in the day for directional

The checkpoint inhibitor was associated with better survival and adverse events vs single-agent chemo for advanced NSCLC. The study was published as a preprint and has not yet been peer reviewed.

Industry Leader Brings Three Decades of Strategic Clinical and Corporate ExpertiseCAMBRIDGE, Mass., Jan. 5, 2023 /PRNewswire/ -- Remix Therapeutic...

Wilson Enhances Their Commercial Portfolio With Fiber-delivered DAS Solutions That Serve 150 to 5,000 MHz in Any Size Venue From a Single Hub Wilson Electronics, the industry leader in cellular